215 related articles for article (PubMed ID: 17925564)
21. Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia.
Otero L; Ornellas MH; Dobbin J; de Souza Fernandez T
Int J Lab Hematol; 2008 Aug; 30(4):346-8. PubMed ID: 18665834
[No Abstract] [Full Text] [Related]
22. Presentation of childhood CML mimicking bone sarcoma.
Radhakrishnan S; Das P; Singh S; Kalita D; Gupta SD; Bakhshi S
Pediatr Blood Cancer; 2009 Jul; 52(7):901-2. PubMed ID: 19214978
[No Abstract] [Full Text] [Related]
23. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment.
Kawakami Y; Nakamura K; Nishibu A; Yanagihori H; Kimura H; Yamamoto T
Acta Derm Venereol; 2008; 88(2):185-6. PubMed ID: 18311459
[No Abstract] [Full Text] [Related]
24. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance.
Gold JS; Dematteo RP
Ann Surg Oncol; 2007 Apr; 14(4):1247-8. PubMed ID: 17265116
[No Abstract] [Full Text] [Related]
25. A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report.
Lao XM; Ye ZY; Guo RP; Guo ZX; Wang GH; Li JQ; Zhang YQ
Acta Oncol; 2009; 48(6):934-7. PubMed ID: 19241185
[No Abstract] [Full Text] [Related]
26. Exfoliative dermatitis with leukemia cutis in a patient with chronic myeloid leukemia: a rare association.
Raj A; Rai R; Rangarajan B
Indian J Dermatol Venereol Leprol; 2011; 77(2):208-10. PubMed ID: 21393960
[No Abstract] [Full Text] [Related]
27. Chronic myeloid leukemia and ankylosing spondylitis.
Ben Abdelghani K; El Menaa M; Ben Abdelghani K; Souabni L; Belhadj S; Chekili S; Laatar A; Zakraoui L
Tunis Med; 2012 Dec; 90(12):901. PubMed ID: 23247779
[No Abstract] [Full Text] [Related]
28. Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia.
Uchiyama M; Ikeda T
Leuk Res; 2009 Dec; 33(12):1723-4. PubMed ID: 19580999
[No Abstract] [Full Text] [Related]
29. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
30. Leukocytosis: the mysteries within.
Munoz J; Guo Y
Am J Hematol; 2012 Feb; 87(2):197. PubMed ID: 21815181
[No Abstract] [Full Text] [Related]
31. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
Janssen JJ; Berendse HW; Schuurhuis GJ; Merle PA; Ossenkoppele GJ
Am J Hematol; 2009 Oct; 84(10):679-82. PubMed ID: 19658186
[No Abstract] [Full Text] [Related]
32. Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
Arancibia AM; Bendit I; Epelman S
Pediatr Blood Cancer; 2008 May; 50(5):1078. PubMed ID: 18085674
[No Abstract] [Full Text] [Related]
33. [Review of 32 gastro-intestinal stromal tumours with CD117 antigen].
Lahmar-Boufaroua A; Ben Slama S; Bouraoui S; Gharbi L; Goutallier C; Manai S; Gharbi W; Mzabi-Regaya S
Tunis Med; 2009 Feb; 87(2):133-6. PubMed ID: 19522447
[TBL] [Abstract][Full Text] [Related]
34. BCR-ABL1 tyrosine kinase activity at diagnosis, as determined via the pCrkL/CrkL ratio, is predictive of clinical outcome in chronic myeloid leukaemia.
Lucas CM; Harris RJ; Giannoudis A; Knight K; Watmough SJ; Clark RE
Br J Haematol; 2010 May; 149(3):458-60. PubMed ID: 20067558
[No Abstract] [Full Text] [Related]
35. Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
Stagno F; Vigneri P; Del Fabro V; Stella S; Massimino M; Berretta S; Messina A; Di Raimondo F
Leuk Res; 2009 Jun; 33(6):e17. PubMed ID: 19036439
[No Abstract] [Full Text] [Related]
36. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
37. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
Chien JH; Tang JL; Chen RL; Li CC; Lee CP
Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
[TBL] [Abstract][Full Text] [Related]
38. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
39. Contemporaneous pulmonary sarcoidosis and chronic myeloid leukemia.
Pavithran K; Doval DC
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):157. PubMed ID: 15281438
[No Abstract] [Full Text] [Related]
40. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
Dvorak P; Hruba M; Subrt I
Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
